Zobrazeno 1 - 10
of 11
pro vyhledávání: '"510"'
Publikováno v:
Blood. 116:5156-5156
Abstract 5156 BACKGROUND: Iron deficiency anemia (IDA) is the most common cause of anemia worldwide. The World Health Organization (WHO) estimates that as many as 1.6 billion people worldwide (25% of the world’s population) have IDA, and the Nation
Publikováno v:
Blood. 110:2679-2679
Iron deficiency anemia is common in the elderly. It is an important medical issue particularly in patients with chronic kidney disease (CKD) because of the associated complications, including increased mortality, loss of functional independence, and
Autor:
Xiangxiang Zhou, Zheng Tian, Ming Liu, Xiaosheng Fang, Lingyan Zhang, Ya Zhang, Xin Wang, Ying Li, Peipei Li
Publikováno v:
Blood. 138:3745-3745
Introduction The epidemiological features of chronic lymphocytic leukemia (CLL) are different in the United States (US) and China. In addition to variant incidence rates, the median age at diagnosis of CLL patients in the Shandong Provincial Hospital
Autor:
Caroline Thomas, Thierry Guillaume, Fanny Rialland, Pierre Peterlin, Patrice Chevallier, Philippe Moreau, Richard Garand, Soraya Wuilleme, Victor Floc'h, Camille Debord, Marie C. Béné, Marion Eveillard, Nelly Robillard
Publikováno v:
Blood. 128:5268-5268
Introduction: CD38 is a type II transmembrane glycoprotein expressed on immature T and B lymphocytes (thymocytes and hematogones), NK cells, activated T-cells, plasma-cells, monocytes and red blood cells. This ectoenzyme is a ribonucleosyl cyclase (C
Autor:
Dron Gauchan, Mithat Gonen, Mark Tharnish, Mehmet Sitki Copur, Max Norvell, John A Wagoner, Ryan C. Ramaekers, Douglas Clark, Erin DeBolt
Publikováno v:
Blood. 126:4553-4553
Background Although oral iron therapy is often the initial approach for the treatment of iron deficiency anemia (IDA) many patients fail to respond and tolerate. Approved parenteral iron treatment options have inconvenient dosing schedules, safety wa
Autor:
Anne-Ségolène Cottereau, Jehan Dupuis, Stefano Luminari, Loïc Chartier, Judith Trotman, Michel Meignan, Gilles Salles, Corinne Haioun, Ilaria Grassi, Hervé Tilly, Annibale Versari, Rene-Olivier Casasnovas, Sami Boussetta, Massimo Federico
Publikováno v:
Blood. 126:3919-3919
Introduction The prognosis for patients with high tumor burden follicular lymphoma (FL) continues to improve in the modern immunochemotherapy era. However there is still a subgroup of 20% of patients who progress within 2 years of first line R-CHOP,
Autor:
Günter Fingerle-Rowson, Richard Houghton, Michael Hallek, Karl-Anton Kreuzer, Anja Engelke, Kathryn Humphrey, Ciara L. Freeman, Mark Dixon, Valentin Goede
Publikováno v:
Blood. 124:3339-3339
Background: The administration of anti-CD20 monoclonal antibodies (mAb) in patients with B-cell lympho-proliferative disorders is frequently accompanied by a constellation of signs and symptoms that have been labelled as infusion-related reactions (I
Autor:
Patrizia Guarini, Barry Woodhams, Francesco Bernardi, Nicola Martinelli, Oliviero Olivieri, Marcello Baroni, Federica Tosi, Barbara Lunghi, Domenico Girelli
Publikováno v:
Blood. 122:2339-2339
Introduction Plasma concentration of activated factor VII (FVIIa)-antithrombin (AT) complex has recently been proposed as a marker of intravascular exposure of tissue factor (TF) and, thus, of activation of the extrinsic pathway of coagulation cascad
Publikováno v:
Blood. 120:3204-3204
Abstract 3204 For the majority with iron deficient anemia (IDA) a standard full repletion course of IV iron is 1 g. Iron sucrose and ferric gluconate require 4–10 administrations of 100–300mg to deliver a full course. We have employed TDI of 1 g
Publikováno v:
Blood. 110:1875-1875
Background Patients with malignancy have an overall 4-fold increased relative risk of developing a venous thrombosis. Central venous catheters are commonly used in patients with cancer (chemotherapy, blood products, parenteral nutrition, etc) and fur